EFALIZUMABUM

EFALIZUMABUM Chemische Eigenschaften,Einsatz,Produktion Methoden

Originator

XOMA (US)

Verwenden

Treatment of transplant rejections; antipsoriatic (immunomodulator monoclonal antibody which decreases the activation, migration, and adhesion of T-cells). hu1124; anti-CD11a.

Trademarks

Raptiva

EFALIZUMABUM Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

EFALIZUMABUM Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Aladdin Scientific	+1-+1(833)-552-7181	sales@aladdinsci.com	United States	57511	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10351	58
ShangHai Biochempartner Co.,Ltd	17754423994 17754423994	2853530910@QQ.com	China	8014	62
Guangzhou Hongyuan Chemical Co.,Ltd	15817493340	981810490@qq.com	China	1565	58
AntibodySystem	18162686757 18162686757	info@biolabreagent.com	China	9818	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 13720134139	orders@jknbiochem.com	China	5462	58
Shanghai Aladdin Biochemical Technology Co.,Ltd.	+86-18521732826	market@aladdin-e.com	China	48465	58
Changsha Fuzhen Biotechnology Co.，LTD	13823398779 18670069958	313359644@qq.com	China	3195	58
TargetMol Chemicals Inc.	15002134094	marketing@targetmol.cn	China	28082	58
Olix (Shanghai) Pharmaceutical Technology Co., Ltd	17316404525	209533805@qq.com	China	9723	58

---

• EFALIZUMABUM
• Research Grade Efalizumab(DHD41001)
• Efalizumab (anti-ITGAL)
• Hu1124|||HU 1124
• 214745-43-4